Association of macromolecular prodrugs consisting of adriamycin bound to poly(L-glutamic acid) by Nukui, Masahiro et al.
Makromol. Chem. 192,2925 -2942 (1991) 2925 
Association of macromolecular prodrugs consisting of 
adriamycin bound to poly(L-glutamic acid) 
Masahiro Nukui”), Kees Hoes: Hans van den Berg, Jan Feijen 
Department of Chemical Technology, University of Twente, P. 0. Box 217, 7500AE Enschede, 
The Netherlands 
(Date of receipt: December 28, 1990) 
SUMMARY 
Soluble macromolecular conjugates for the controlled delivery of the strongly hydrophobic 
antitumor drug adriamycin (ADR) were prepared. The association behaviour of two types of these 
amphiphilic conjugates consisting of ADR bound to poly(L-glutamic acid) (PGA) in aqueous 
solution was investigated using absorbance and fluorescence spectroscopy as well as GPC and low- 
angle laser light scattering (LALLS) measurements. ADR was bound via the aminoribosyl moiety 
either directly with PGA side-chain groups or via oligopeptide spacer groups. UV/VIS, GPC and 
LALLS data showed that in buffer solution both ADR conjugates associate intermolecularly. The 
data of the directly bound ADR conjugates are consistent with the presence of multimers of 
different degrees of association in equilibrium with single polymer chains. In contrast, spacer- 
containing ADR conjugates associate to give stable uniform multimers. UV/VIS and fluorescence 
spectroscopy performed at very low conjugate concentration show that polymer-bound ADR 
residues associate intramolecularly as well. The degree of intra- and intermolecular association 
of the conjugate-bound ADR molecules depends on the type of conjugate, ADR load and 
conjugate concentration as well as on ionic strength of the solvent, the presence of organic 
cosolvents and temperature. The data indicate that hydrophobic domains in spacer-containing 
conjugates are more stable compared with directly bound conjugates, probably due to enhanced 
flexibility and the presence of hydrophobic leucine residues. It is concluded that spacer-containing 
conjugates of ADR may have a potential for effective drug delivery under in vivo conditions due 
to their solution properties in addition to the biodegradability of the drug-polymer bond. 
Introduction 
Macromolecular prodrugs consisting of antitumor agents coupled to water-soluble 
polymeric carriers have been developed to improve chemotherapy with less toxic side 
effects‘,2,3). The design of soluble drug conjugates usually conforms to either one of 
two general strategies: The drug is bound to the carrier via a hydrolytically labile bond 
resulting in a sustained release of drug in the circulation, thereby preventing toxic peak 
concentrations of free drug ‘). Alternatively, the drug is bound to the carrier through 
a bond which is stable in the circulation and which is cleaved after pinocytic uptake of 
the conjugate by cells either by lysosomal enzymes or by the acid environment of endo- 
somes and lysosomes. The latter approach may have potential for enhanced selectivity 
towards certain tumor cells with an enhanced rate of uptake of macromolecules 5 ,6 ) .  
Most drugs are hydrophobic, and upon binding to a hydrophilic polymeric carrier 
a conjugate is obtained having amphiphilic properties in aqueous s ~ l u t i o n ~ ~ ~ ~ ~ ) .  As a 
result, drug conjugates may associate intramolecularly affecting the conformation of 
a) Present address: Research center, Mitsubishi Kasei Corporation, 1000, Kamoshida-cho, 
Midori-ku, Yokohama 227, Japan. 
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single chains as well as intermolecularly yielding formation of multimers. Association 
phenomena have been shown to occur for polymer-bound p-nitroaniline used as a 
model drug8) and for polyelectrolyte-bound phenanthryl groups 9, but have not yet 
been studied in detail for polymeric conjugates of clinically used drugs. The therapeutic 
effectivity of macromolecular drug conjugates is dependent on biodistribution, 
including capture by cells of the reticulo-endothelial (RES) system and binding with 
plasma proteins, as well as the mode and rate of uptake by cells and the drug release 
rate. These properties may be altered in drug-polymer conjugates compared with 
polymeric carriers due to drug-mediated association phenomena. 
In previous papers we described macromolecular conjugates of the antitumor drug 
adriamycin (ADR) using sodium poly(L-glutamate) (PGA), as a soluble biodegradable 
carrier The design of these drug conjugates aims at lysosomal release of drug 
after pinocytic uptake by cells. The rate of drug release is regulated by using 
oligopeptide spacers of specific composition between drug and carrier. We have 
reported on the syntheses of conjugates having oligopeptides of different composition 
as spacer units lo), interaction with an in vitro cytotoxicity against L1210 leukemia 
cells ", '') and enzyme-mediated drug release "). 
ADR is known to be very prone to adsorption to surfaces and to formation of dimers 
in solution due to the hydrophobic nature of the aglycone moiety 1 3 ) .  By limiting the 
level of substitution of polymer with this hydrophobic drug to low values, the conjuga- 
tes can be kept solubleI0). The amphiphilic nature of ADR conjugates may also result 
in intramolecular and/or intermolecular association affecting essential aspects of the 
performance of a drug conjugate such as biodistribution, transport properties, uptake 
by cells and rate of drug release. 
In this paper the solution properties of ADR conjugates derived from PGA are 
described using GPC and low-angle laser light scattering (LALLS) to characterize the 
behaviour of the polymer and UV/VIS absorbance as well as fluoroescence 
spectroscopy to analyze the behaviour of the polymer-bound drug. Two different types 
of ADR conjugates were prepared by coupling ADR either to the y-carboxyl groups of 
PGA or to the Leu carboxyl groups of PGA-GlyGlyGlyLeu grafts"). The suitability 
of GlyGlyGlyLeu-containing ADR conjugates for controlled drug delivery is suggested 
by the observation that free drug as well as amino acid and peptide derivatives of the 
drug are released upon incubation with lysosomal enzymes1'). The effects of 
conjugate structure, concentration and drug load as well as solvent composition and 
temperature on the association of the conjugates were studied. 
Results 
Preparation of poIymeric carriers and polymer-drug conjugates 
Poly(y-benzyl-L-glutamate), PBLG, was prepared according to the method of Blout 
and Karlsont4) using dioxane as the solvent. Debenzylation of PBLG was carried out 
using trifluoroacetic acid (TFA)/methanesulfonic acid (MSA) according to the proce- 
dure 15) reported for the preparation of low-molecular-weight PGA. The reaction con- 
ditions were optimized in order to prepare PGA having the lowest possible amount of 
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residual benzyl groups while maintaining a high molecular weight. The results are 
summarized in Tab. 1 .  
It was found that benzyl groups were removed very rapidly after the addition of MSA 
to the TFA solution of PBLG. Scission of polymer main chains took place gradually. 
As a result high-molecular-weight PGA (av = 7,3 . lo4) with a low residual amount 
of benzyl groups (0,4 mol-To) could be obtained after reaction of PBLG for 20 min at 
0 "C and 13 min at room temperature. The classical debenzylation method using 
Tab. 1. Syntheses of poly(r-glutamic acid) (PGA) from poly(y-benzyl L-glutamate) (PBLG) a) 
Run Time in min b, Residual benzyl a,,') 
groups in mol-Vo 
at 0°C at room temperature 
1 0 0 
2 10 0 
3 20 0 
4 20 13 
5 20 15 
6 20 30 
a) Debenzylation of PBLG using trifluoroacetic acid and methanesulfonic acid (see Exptl. part). 
Parent PBLG: a,, = 206000 (determined by viscometry in dichloroacetic acid). 
b, Time after adding methanesulfonic acid into a trifluoroacetic acid solution of PBLG. 
') Determined by viscometry (see Exptl. part). 
d, No water-soluble polymer obtained. 
e ,  a, could not be determined because of a high amount of residual benzyl groups. 
hydrogen bromideI6) in toluene yields PGA having ca 1 mol-To of benzyl groups after 
a reaction time of 1 day at room temperature'7). The amount of residual benzyl 
groups could be suppressed by increasing the reaction time, but the molecular weight 
of PGA decreased significantly 17). Therefore, debenzylation using TFA/MSA is more 
convenient for the preparation of high-molecular-weight PGA having low residual 
amounts of benzyl groups. 
The syntheses of ADR conjugates were performed as described earlier lo). Direct 
coupling of ADR onto PGA was carried out by using N-ethoxycarbonyl-2-ethoxy- 
1,2-dihydroquinoline, EEDQ, as a coupling agent (Scheme 1, PGA-ADR, 3). The 
attachment of ADR onto PGA through spacer groups was carried out by the following 
two steps (Scheme 1 ,  PGA-GlyGlyGlyLeu-ADR, 4). First, PGA was grafted with the 
oligopeptide spacer, GlyGlyGlyLeu ' I )  by preactivation of PGA with saccharin and 
N,N-carbonyldiimidazole (CDI) in DMF and subsequent reaction of the saccharin 
imides with the N,N,N,N-tetramethylguanidinium salt of the oligopeptide. Then, 
ADR was coupled onto the grafted polymer 2 using EEDQ. The results of the prepara- 
tions of ADR conjugates are summarized in Tab. 2. 
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1) CDI, saccharin 
2) GlyGlyGlyLeu 
PGA b 
1 ADR I EEDQ 
PGA-ADR 
3 
PGA-GlyGlyGly Leu 
2 
ADR 
EEDQ I 
PGA-GlyGlyGly Leu-ADR 
4 
p 2  
1 COOH - Coupling site 
GlyGlyGlyLeu : 
NH#J~TCO-NH-C~-CO-NH-CH-CO--NH-CH-COOH 
I 
Scheme I: Syntheses of two types of adriamycin conjugates: directly coupled conjugate 3 and 
spacer-coupled conjugate 4 
Tab. 2. Macromolecular prodrugs of adriamycin a) 
Code b, Drug loadc) Yield of 
conjugates in 070 
in mol-% in wt.-% 
3a 
3b 
3c 
4a 
4b  
93 
97 
97 
90 
88 
a) Derived from poly(r;glutamic acid) (PGA, 1; Gv = 73 OOO, residual benzyl groups 0,4%) and 
PGA-oligopeptide grafts (PGA-GlyGlyGlyLeu, 2; spacer load: 77 mol-%, determined by 'H 
NMR measurements). 
b, 3a-c: Directly coupled conjugates (PGA-ADR), 4 a, 4 b: spacer-coupled conjugate (PGA- 
GlyGlyGlyLeu-ADR) (see Scheme 1). 
') Determined by UV-VIS measurements (see Exptl. part). 
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GPC measurements 
The intermolecular association behavior of ADR conjugates in buffer solution was 
investigated by GPC. The effects of ADR load, spacer units and ionic strength of the 
solvent were studied. 
Fig. 1 shows elution curves of the parent polymer PGA (1) and directly coupled ADR 
conjugates 3a and 3b in phosphate buffer containing 0,l M NaCl, pH 7,O. At this pH, 
PGA is completely ionized 18), and it is assumed that conjugates are also completely 
ionized. The elution curve of 1 shows a single broad peak at an elution volume (V,) of 
174 mL. The void volume of the column used was determined to be 155 mL using Blue 
Dextran 2000 with mw = 2 - lo6 g . mol-’. Hence, 1 penetrates into the gel pores. The 
shape of the elution curves of the conjugates depends on the amount of ADR molecules 
attached to the polymeric carrier. After the binding of a small amount of drug onto 
the PGA main chain (3 a, ADR load 1,8 mol-%), early-eluting new peaks are observed 
at V, = 165 (shoulder) and 168 mL indicating the presence of high-molecular-weight 
products. With higher drug loads, as in the case of 3 b (ADR load 4,O mol-Yo), the early- 
eluting peaks (V, = 161, 164 and 166 mL) become predominant. Apparently, the 
formation of multimeric products is mediated by the polymer-bound drug. Further, 
multimers of various molecular weights seem to be present indicating ‘open-type’ 
association of polymer chains j9). 
The shape of the elution curves is also dependent on the type of conjugate. Fig. 2 
shows elution curves of the parent polymer PGA-GlyGlyGlyLeu (2) and spacer-coupled 
ADR conjugates 4 a and 4 b. The elution curves of conjugates 4 a and 4 b having 1,3 and 
4,8 mol-Yo of bound ADR, respectively, are similar and show two peaks. V,  of the 
major peak due to low-molecular-weight material (173 mL) is almost identical with that 
of the parent polymer 2 (V,  = 175 mL). A minor peak due to high-molecular-weight 
conjugate (V ,  = 160 mL) appears at the void volume. Qualitatively, the extent of 
multimer formation by the spacer-bound conjugates 4a and 4b is much lower 
compared with the directly bound conjugates 3a and 3b. 
Fig. 1. GPC elution curves of 
parent PGA (1) and directly 
coupled adriamycin conjugates (3 a 
and 3 b) in 0,Ol M sodium 
phosphate solution containing 
NaCl (0,l M or 0,5 M), pH 7,O 
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M. Nukui, K. Hoes, H. van den Berg, J. Feijen 2930 
m 
V 
C 
0 e 
n 
Q 
m Void volume 
1 r 4 a = b b  (0.1~) 
I I I I I 
Fig. 2. 
oligopeptide-grafted PGA (2) and 
adriamycin conjugates coupled via 
oligopeptide spacer (4a and 4 b) in 
0,Ol M sodium phosphate solution 
containing NaCl (0,l M or 0,5 M), 
GPC elution curves of 
PH 7,o 
100 200 300 
Elution volume in rnL 
Finally, the shape of the GPC curves of ADR conjugates is affected by the ionic 
strength of the eluent. In a solvent of high ionic strength (0,5 M NaC1-phosphate buffer) 
the formation of multimers is suppressed for conjugate 3 b and is not detectable any 
more for conjugate 4 b compared with 0,l M NaCl phosphate buffer (Figs. 1 and 2). The 
elution curves of the parent polymers 1 and 2 are independent of the ionic strength of 
the eluent. 
Low-angle laser light scattering (LALLS) measurements 
The ADR conjugates were studied by LALLS to obtain molecular weights and 
additional evidence for intermolecular association. Errors in the determination of 
molecular weights due to Donnan-type exclusion of salts from the polyelectrolytes were 
suppressed by dialyzing the polymeric conjugates against the appropriate buffer 
solution 20). Fig. 3 shows the concentration dependence of the reciprocal apparent 
molecular weight (l/aw app = Kc/AR, K is the optical constant, c the concentration 
of the polymer and AR the Rayleigh ratio) observed for the ADR conjugates 3b and 
4 b in 0,Ol M phosphate buffer solution at pH 7,O containing 0,l or 0,5 M NaCl. 
The salt concentration affects the concentration dependence of l/awaPp as well as 
the average molecular weight obtained by extrapolation of the curves to zero concentra- 
tion (&?w,,). In 0,l M NaCl both conjugates show positive values of the second virial 
coefficients (2,7-4,9 mol cm3 . g-2) typical for thermodynamically good polymer- 
solvent interactions. The values are much smaller than observed for parent PGA, 1 (47 
mol . cm3. g-2). This may indicate a less expanded polymer conformation due to 
intramolecular association mediated by the coupling of drug (3 b) or spacer and drug 
(4 b) 19). The initial decrease of l/mwapp with increasing concentration observed for 4b 
may be explained by the presence of multimeric associates 19). 
In 0,5 M NaCl the slopes of the plots are slightly negative (3 b) and slightly positive 
(4b), respectively. The decrease of l / ~ w , p p  with increasing concentration, i. e. a 
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Fig. 3. Low-angle laser light scattering data of adriamycin conjugates in 0,Ol M sodium 
phosphate solution containing NaCl (empty symbols: 0,l M; filled symbols: 0,5 M), pH 7,O. (a): 
Directly coupled conjugate 3 b, (b): spacer-coupled conjugate 4b 
negative virial coefficient, observed for 3 b is evidence for the presence of significant 
amounts of multimeric associates i9). In contrast, the concentration dependence of 
l/mwapp observed for 4b is very slight, the small positive slope indicating polymer- 
solvent interaction close to theta-conditions with no evidence of multimer formation. 
By extrapolation of the curves to zero concentration the values of the average 
molecular weight, ii?w,ex,,, of the unimer should be obtained 19). Thus, conjugate 3 b 
shows an Mw,,,, of 4,s . lo5 g * mol-I or 2,6 lo5 g mol-' in phosphate buffer 
solution containing 0,l M NaCl or 0,5 M NaCl, respectively. These values are larger than 
the unimer molecular weight (1,5 . lo5 g mol-I) calculated from the molecular 
weight of the parent polymer 1 determined by LALLS (1,27 * lo5 g * mol-') and the 
composition (drug load 4,O mol-'To). This can be interpreted by assuming that 
multimers of 3 b, presumably trimers (0,l M NaCl) or dimers (0,5 M NaCl), are present 
below the lowest concentration used. The mw,exlr of conjugate 4 b  is 2,6 * lo5 g mol-' 
or 2,5 * lo5 g mol-' in buffer solution containing 0,l M NaCl or 0,5 M NaCl, 
respectively. These values are smaller than the unimer molecular weight (3,9 * lo5 
g-mol-I)  calculated from the molecular weight of the parent polymer 1 and the 
composition (spacer load 77 mol-'To, drug load 4,s mol-'To). The smaller i@w,ex,, 
determined by LALLS may be explained by the occurrence of some polymer main 
chain bond cleavage due to the strongly basic reaction conditions in the preparation 
of the spacer-grafted carrier lo) 2. It should be pointed out that the values of mw,,,, are 
apparent and at low concentration may still deviate from the true values due to 
polyelectrolyte effects. Hence, values obtained in 0,5 M NaCl are probably more reliable 
than those obtained in 0,l M NaCl. 
Concentration dependence of UWVIS and fluorescence spectra 
The ADR conjugates were studied by UV/VIS and fluorescence spectroscopy which 
are drug-specific optical techniques allowing to obtain information on hydrophobic 
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domains. Free ADR and related compounds are known to associate in aqueous solution 
yielding dimers and higher-order oligomers with association constants in the order 
of13) lo3 to lo4 mol-' * L. The type and extent of association of free ADR has been 
shown to depend on pH (amount of free base), salt concentration, solvent composition 
and temperature using different techniques: UV/VIS absorbance2'-23), 
fluorescence2'), circular dichroism 21,24) and NMR22*24*25). In macromolecular ADR- 
PGA conjugates similar hydrophobic interactions between drug moieties may occur 
and will compete with solvation of the polymer backbone and side chains and 
electrostatic interactions between side chain carboxylate groups. 
Figs. 4 and 5 show the absorption spectra at different concentrations of free ADR 
or the conjugate 3 bin 0,Ol M phosphate buffer solution (pH 7,O) containing 0,l M NaCI, 
respectively. The spectra of free ADR in buffer solution at concentrations of 1,3; 13 
and 300 vmol. L- '  correspond with previously published spectraz1). The spectrum 
measured at the highest concentration used (300 pmol. L - I )  indicates the presence of 
ADR dimers which show the absorption maximum (Amax) at 483 nm. On decreasing 
the concentration of drug (13 Rmol' L-I), a shoulder appears at a higher wavelength 
7 15 
E 
Monomer 
LOO 500 600 
A/nm 
- 15000 
; - - : 
10000 - 
'a 
Ip 
rn 
5000 
LOO 500 600 
A/nm 
Fig. 4. Absorption 
spectra of free 
adriamycin (apparent 
extinction coefficient capp 
vs. A) at different 
concentrations in 0,Ol M 
sodium phosphate 
solution containing 0,l M 
NaC1, pH 7,O 
Fig. 5.  Absorption 
spectra of adriamycin 
conjugate 3 b at different 
concentrations of bound 
drug in 0,Ol M sodium 
phosphate solution 
containing 0,l M NaCI, 
PH 7,O 
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than A,,. At very low concentration (1,3 pmol*L-') ,  the shape of the spectrum 
indicates the presence of monomeric ADR which shows A,,, at2') 498 nm. The 
association constant (K,) is calculated from the concentration dependence of the 
apparent extinction coefficient using a simple dimer model2'). The value of K ,  is 6 100 
mol * L- '  similar to previously reported data2'x23). 
The spectra of conjugate 3 b (Fig. 5 )  show the absorption maximum at 483 nm 
characteristic of dimeric ADR at all drug concentrations studied down to 1,l 
pmol - L-' (conjugate concentration 4,7 . g * mL-'). Similar results were 
obtained for ADR conjugates with oligopeptide spacer (4a, 4b). These data indicate 
that ADR molecules present in the conjugates associate at very low conjugate 
concentration probably due to intramolecular interactions. It should be realized that 
the local drug concentration within polymer chains is generally much higher than in 
a solution of free ADR at a comparable total concentration of drug. 
Figs. 6 and 7 show the concentration dependence of the apparent extinction 
coefficient (tapp at 483 nm) of directly bound or spacer-bound ADR conjugates, 
respectively. The tapp values of the directly coupled conjugates 3a and 3c decrease 
gradually on increasing the conjugate concentration. This indicates the formation of 
multimers having different degrees of association according to the 'open association 
type' mechanism. At high concentration no constant value of tapp was reached 
indicating partial multimer formation. The magnitude of the total change in tapp 
(1 500 L . mol-' . cm-') for both conjugates is appreciable but smaller than that of 
free ADR (3000 L . mol-' * cm-I). Both, environmental changes and extent of 
multimer formation contribute to the change in tapp. The tapp values of the spacer- 
containing conjugates 4a and 4b (Fig. 7) are almost constant up to a certain 
d 
10 I:] 
9+ 
10-2 lo-' 100 10' 
1000. c/ig/rnL) 
4a 
4b 
10-2 10-1 100 10' 102 
1000. c/(g/mL) 
Fig. 6. Fig. 7. 
Fig. 6. Dependence of apparent extinction coefficient (at 483 nm) on polymer concentration c 
of directly coupled conjugates 3a (0 )and 3c (0)  in 0,Ol M sodium phosphate solution containing 
0,l M NaC1, pH 7,O 
Fig. 7. Dependence of apparent extinction coefficient (at 483 nm) on polymer concentration of 
spacer-coupled conjugates 4a (0) and 4b (W) in 0,Ol M sodium phosphate solution containing 
0,l M NaC1, pH 7,O. Arrows indicate the onset of intermolecular association 
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concentration, then decrease sharply and attain again constant values at a higher 
concentration range. The steep transition indicates that the spacer-bound conjugates 
yield multimers of constant degree of association according to the 'closed association 
type' mechanism. The critical polymer concentration above which the cap,, values 
decrease sharply depends on the ADR load of the conjugates (8 . g - mL-' for 
4a, 2 .  g * m L - '  for 4b). The total change in capp is rather small (500 
L * mol-' cm-I) indicating a minor change in chromophore environment upon 
multimer formation. 
The interaction of polymer-bound ADR molecules was also investigated using fluor- 
escence spectroscopy. Fig. 8 shows the concentration dependence of the normalized 
fluorescence intensity (observed fluorescence intensity divided by concentration, 
excitation at 475 nm, emission at 550 nm) of free ADR and the conjugates 3a-c. The 
fluorescence intensity of free ADR is quenched strongly at concentrations above 3 
vmol- L-I due to stacking interaction in the dimerz'). On the other hand, a remark- 
able fluorescence quenching was observed for all ADR conjugates even at very low drug 
concentrations below 1 pmol. L- ' .  This supports the presence of interactions 
between drug moieties, bound to the same polymer molecule, as concluded from the 
UV/VIS absorbance data. The fluorescence intensity of the conjugates decreases 
slightly in the concentration range of 1-20 pmol. L-I consistent with the onset of 
multimer formation observed by UV/VIS absorbance. 
Effect of solvent composition and temperature on UV/ VIS and fluorescence spectra 
The association of ADR conjugates is expected to depend on the hydrophobic 
interaction between drug molecules as well as on the conformation of the polymeric 
carrier. At pH 7,0, PGA is anionically charged and assumes an unordered 
conformation in solutions containing salts, the dimension of PGA being dependent on 
the ionic strength of the solvent 18,26).  By adding organic solvent a transition towards 
an a-helical conformation occurs '@. Further, the dimerization equilibrium of anthra- 
cyclines is shifted towards free drug in the presence of organic solvents2'). On this 
10 I 
1 10 100 
IADRl/(prnol. L-') 
Fig. 8. Dependence of 
normalized fluorescence intensity 
F,,,, on the total drug 
concentration of free adriamycin 
and directly coupled conjugates 
3a, 3b  and 3c in 0,Ol M sodium 
phosphate solution containing 0,l 
M NaCI, pH 7,O. I ,  = 475 nm, 
Aem = 555 nm 
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basis the association of ADR conjugates derived from PGA may be well dependent on 
the ionic strength and polarity of the solvent. 
The effect of salt concentration and methanol addition on the UV/VIS spectra of 
conjugate 3b at low concentration (1  * lo-' mole L-') was studied (Tab. 3). The 
spectrum measured in a mixture of phosphate buffer (0,Ol M sodium phosphate, 
pH 7,0, no NaCl) and methanol (50/50 v/v) (Tab. 3, run 1 )  is similar to that of the 
monomeric form of free ADR. This indicates that covalent linkage of ADR to PGA 
does not change the spectrum and that no drug-drug interactions in the polymeric 
conjugate occur. Addition of NaCl to the aqueous methanol solution induces 
association of polymer-bound drug (Tab. 3, run 2). 
Tab. 3. Absorbance spectra data of conjugate 3b measured in various solventsa) 
Run Solution composition Shape of E ~ ~ ~ .  i ~ - ~ / ( ~ . m o i  - I .cm 
spectrum b, 
NaCl in Methanol in 483 nm 498 nm 
mol . L- '  VOLVO , 
~- 
1 0 50 U 12,o 12,l 
2 0,1 50 D l l ,o  1 l,o 
3 0 0 D 11,4 11,4 
4 071 0 D 10,4 10,3 
5 1 ,o 0 D 9,6 994 
a) Measured in phosphate buffer: 0,Ol M phosphate, pH 7,0, [ADR] = 10 kmol. L- ' .  
b, D: dimer form, U: unimer form. 
The effect of increasing ionic strength on the association of the ADR conjugates in 
purely aqueous solutions is demonstrated by changes in capp. In 0,Ol M sodium 
phosphate, pH 7,0, capp values of 3b at low concentration (1 . lo-' mol 1 L-') are 
lower than in the presence of methanol, thus indicating the presence of drug-drug 
interactions. With increase of NaCl concentration up to 1 mol/L the capp of 3b in 
aqueous solution decreases even further (Tab. 3, runs 3 - 5 ) .  
mol . L-I) on ionic strength. The fluorescence intensity of both conjugates decreases 
on increasing the ionic stength indicating enhanced association of polymer-bound 
ADR molecules. The fluorescence intensity of 3 b is more sensitive to ionic-strength 
variation than that of 4 b indicating that 3 b is more sensitive to salt-induced polymer 
contraction and enhancement of hydrophobic interaction. The enhanced association 
of drug molecules in 3 b at high salt concentration is probably intramolecular because 
the LALLS data at low conjugate concentration indicate less multimer formation 
under these conditions (Fig. 3). 
The effect of temperature on the association of the ADR bound to the conjugates 
is illustrated by changes in the normalized fluorescence intensity. Fig. 10 shows that the 
fluorescence intensity of conjugate 3 b increases with increasing temperature indicating 
a rather limited stability of the ADR domains. On the other hand, the fluorescence 
Fig. 9 shows the dependence of the fluorescence intensity of 3b and 4b (5 . 
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Fig. 9. Effect of ionic strength on 
the normalized fluorescence 
intensity of adriamycin conjugates in 
0,Ol M sodium phosphate solution; 
pH 7,O; 3 b: directly coupled 
conjugate ( o ) and 4 b spacer- 
coupled conjugate (M). The ADR 
concentration for both conjugates 
was 5 .  mol. L - '  
intensity of conjugate 4 b is almost insensitive to temperature change pointing to a 
relatively high stability of ADR domains. The temperature effects were found to be 
reversible. 
Discussion 
Model for the association of ADR conjugates in solution 
From the data presented above we propose a qualitative model for the solution 
behaviour of each type of ADR conjugate (Schemes 2 and 3). At low ionic strength (0,l 
M NaCI) close to physiological conditions the polyelectrolyte-drug conjugates are 
expanded due to strong electrostatic repulsion between polymer-bound carboxylate 
groups. The spacer-containing conjugate 4 forms stable intramolecular hydrophobic 
domains, aided by the flexible spacer arms, at low concentration. At higher concentra- 
1 2.5 
2.0 
15 25 35 15 55 
Temp. in O C  
Fig. 10. 
the normalized fluorescence 
intensity of adriamycin conjugates in 
0,Ol M sodium phosphate solution 
containing 0,l M NaCI, pH 7,O; 3 b: 
(0) and 4b: (M). The ADR 
concentration for both conjugates 
~ a s 5 - 1 0 - ~ m o l . L - '  
Effect of temperature on 
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tions the intramolecularly folded structure of 4 is in equilibrium with stable multimers 
of constant composition. At low concentration the directly coupled conjugate 3 forms 
weakly stabilized hydrophobic domains partly by intermolecular interaction due to lack 
of flexibility between ADR molecules and strong repulsive forces. At high concentra- 
tion the intermolecular association is enhanced, but the limited stability of hydro- 
phobic domains yields randomly associated polymer chains. 
By increasing the salt concentration the electrostatic repulsion between polymer- 
bound charged groups is suppressed, and hydrophobic interaction is enhanced for both 
conjugates. At low concentration intramolecular hydrophobic domains, presumably of 
a compact nature, are formed from 3 as well as 4 (Scheme 3). Towards higher concentra- 
tion, association of polymer chains occurs only for 3 but not for 4 due to its inherently 
more stable intramolecular structure. 
Evidence for multimer formation by ADR conjugates 
UV/VIS and fluorescence data on PGA-derived ADR conjugates (Scheme 1) with 
either 1,3-1,8 mol-Yo (3a, 4a) or 4-5 mol-Yo (3b, 3c, 4b) of bound drug show 
0,l M NaCl phosphate buffer 
Conjugate 3 
a low conc. 
Conjugate 1 
high conc. -- 
low conc. 
Scheme 2: Association behaviour of directly coupled conjugate 3 and spacer-coupled conjugate 
4 at low ionic strength (0,l M NaCl phosphate buffer) 
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0,5 M NaCl phosphate buffer 
Conjugate 3 
high conc. -
low conc. 
Conjugate 4 
high conc. -
low conc. 
e lea 
Scheme 3: Association behaviour of directly coupled conjugate 3 and spacer-coupled conjugate 
4 at high ionic strength (0,s M NaCl phosphate buffer) 
evidence for hydrophobic interaction at  very low concentrations in 0,l M NaCl- 
containing buffer solution. Notably, the shape of the UV/VIS spectra of polymeric 
conjugates is very similar to that of the dimer of ADR which exists in solution due to 
the hydrophobic character of the drug aglycone2'-23). The polymeric conjugates also 
show a slightly reduced molar absorbance at  maximum wavelength as well as strong 
quenching of drug fluorescence consistent with drug-drug interaction. The tendency of 
polymer-bound drug moieties to interact may be rationalized by the high local drug 
concentration within polymer chains. In principle, this interaction between polymer- 
bound drug moieties can be either intramolecular or  intermolecular yielding multi- 
mers. The average molecular weights obtained from LALLS data after extrapolation 
to zero concentration indicate that the directly bound conjugate 3 b associates 
intermolecularly even at very low concentration, whereas the spacer-containing 
conjugate 4 b is present as the unimer and drug-drug interaction occurs intramole- 
cularly. 
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Various techniques provide evidence for intermolecular association of ADR 
conjugates 3a, 3b  and 3c as well as 4a  and 4b. GPC performed with high conjugate 
concentration shows the presence of both unimers and multimers in 0,l M or 0,5 M 
NaC1-containing solution. Qualitatively, the extent of multimerization is appreciable 
for conjugate 3b having ADR bound directly to PGA both in 0,l M and 0,5 M NaCl 
solution, but is low (0,l M NaCI) or undetectable (0,s M NaCl) for the PGA- 
GlyGlyGlyLeu-derived conjugate 4 b. 
Multimerization of 3 b in 0,s M NaCl solution is also indicated by the negative value 
of the virial coefficient from LALLS. This is in accordance with the molecular weight 
obtained from extrapolation to zero concentration. The presence of unimers of 4b in 
0,s M NaCl solution, as concluded from the molecular weight value obtained by 
extrapolation to zero concentration, is corroborated by the almost zero value of the 
virial coefficient from LALLS. On the other hand, the LALLS data obained for 3 b 
and 4b in 0,l M NaCl indicate relatively large positive values of the virial coefficient 
precluding a definite conclusion on multimers. Numerical analysis of the LALLS 
data'9) is not warranted due to the unknown values of the virial coefficient of the 
unimer as well as the lack of quantitative data on the unimer-multimer equilibrium. 
Both types of conjugate demonstrate concentration-dependent changes in the molar 
absorbance of the ADR chromophore indicative of multimer formation. Importantly, 
the multimer structure of the two types of conjugate appears to be different apparently 
due to the different chemical structure. The directly bound conjugates 3 a and 3 c in 0,l 
M NaCl yield open associates involving differently sized rnultimers as judged from the 
smooth transition in the concentration dependence of the UV/VIS absorbance and 
from the GPC elution profile. In contrast, the spacer-containing conjugate 4a and 4b 
in 0,l M NaCl yield multimers of the closed type characterized by constant association 
number as indicated by the steep transition in the concentration dependence of UV/VIS 
absorbance and by GPC. 
Stability of hydrophobic domains in ADR conjugates 
Various data point to a difference in stability of hydrophobic domains in ADR 
conjugates. Addition of salt enhances the fluorescence quenching of 3 b to a greater 
extent than that of 4 b. Increase of temperature enhances the fluorescence intensity of 
3b but not of 4b. These data indicate that the hydrophobic domains in the spacer- 
containing conjugate 4 b are more stable compared with the directly-coupled conjugate 
3 b. Moreover, the constant ADR absorbance of spacer-containing conjugates 4a and 
4 b at low and high concentration is also consistent with stable ADR domains. Thus, 
the open-type association of directly bound ADR conjugates 3a and 3c may be due 
to relatively weakly stabilized ADR domains. 
Various structural properties of spacer-containing conjugates may contribute to the 
enhanced stability of ADR domains. The presence of hydrophobic Leu residues in the 
spacer may well supply additional stability. Further, the spacer can provide enhanced 
flexibility for interaction of the polymer-bound drug. Also, electrostatic interactions 
between conjugate carboxylate groups opposing hydrophobic interactions of the drug 
might be weaker in spacer-containing conjugates due to the lower charge per molar 
mass and yield more stable ADR domains. 
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Conclusions 
Conjugates o f  ADR bound to polyelectrolyte carriers yield partly multimeric 
products in salt-containing solution. For the application as a soluble conjugate for 
controlled drug delivery such a property is not desirable because the transport of very 
high-molecular-weight materials in the circulation is slow due to  diffusional limita- 
tions, and passage between body compartiments is restricted due to size barriers2q3). 
The present results indicate that ADR conjugates having the drug bound to  
GlyGlyGlyLeu grafts of PGA have a preference for intramolecular folding and may 
therefore act  as better drug carriers compared with directly coupled A D R  conjugates 
which tend to multimer formation. Thus, on the basis of  the present results and the 
previously found lysosomal release of drug from ADR conjugates with GlyGlyGlyLeu 
spacers further studies on this type of conjugate including the therapeutic effective- 
ness are necessary. 
Experimental part 
Materials 
Tetrahydrofuran (THF) and 1.4-dioxane were stirred with finely powdered potassium hydroxide 
(1 0 g/L), filtered and distilled from sodium wire under nitrogen atmosphere. Triethylamine was 
refluxed with phthalic anhydride and distilled. Trifluoroacetic acid (TFA) was distilled after 
refluxing with 1 v01.-% of trifluoroacetic anhydride. Methanesulfonic acid (MSA) was used 
without further purification. All chemicals were obtained from Merck (Darmstadt, F. R. G.). The 
synthesis of GlyGlyGlyLeu will be described in detail elsewhere27). 
Briefly, equimolar amounts of the N-hydroxysuccinimidyl ester of N-triphenylmethylglycine, 
GlyGlyLeu (Sigma, USA) and N-ethylmorpholine were reacted in DMF for 3 days at room 
temperature to give, after workup, N-triphenylmethyl-G1yGlyGlyLeu, homogeneous as judged 
from thin-layer chromatography (TLC) and 'H NMR. The compound was dissolved in 75% 
acetic acid and stirred for 3 h at room temperature. After workup, GlyGlyGlyLeu was obtained 
in an overall yield of 68%. The product was homogeneous as judged from TLC, 'H NMR and 
amino acid analysis. 
Preparation of poly(bg1utamic acid) (PCA) 
y-Benzyl-L-glutamate lo) was reacted with a solution of trichloromethyl chloroformate (TCF) in 
THF as described2@ to give, after two crystallizations from ethyl acetate, the 5-benzyl ester of 
L-glutamic acid N-carboxyanhydride (system. name: 4-(2-benzyloxycarbonylethyl)oxazolidine- 
2,5-dione): yield 32%, m. p. 90-91 "C (ref. 14): 9 3 ~ 9 4 ° C ) .  13,9 g (52,9 mmol) of the latter was 
polymerized in 1,Cdioxane (700 mL) using triethylamine (0,15 mL; 1,08 mmol) as the initiator 
to give poly(y-benzyl L-glutamate) (PBLG). The weight-average molecular weight of PBLG was 
determined via intrinsic viscosity at 25 "C in dichloroacetic acid using the following relation''): 
[q]/(dL. g-') = 2,78. lo-' @dS7. 
Debenzylation of PBLG was performed using TFA/MSA'5). PBLG (8,61 g) was dissolved in 
TFA (70 mL) at room temperature within ca. 1 h. To the solution of PBLG containing anisole (12 
mL), MSA was added with stirring at 0 OC. After stirring for 20 min at 0 "C and for 13 min at 
room temperature (15- 18 "C), the reaction mixture was poured into diisopropyl ether. The crude 
PGA was dissolved in 0,2 M aqueous sodium hydrogen carbonate solution and dialyzed 
exhaustively against deionized water. The solution was filtered and added to diluted HCI solution 
(pH 2) with stirring. The precipitate was collected by filtration, washed with water and freeze- 
dried: the yield was 4,Ol g. The 'H NMR spectrum was in accordance with the structure. The 
content of residual benzyl groups was calculated from UV absorption (in water, A, = 256 nm, 
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molar extinction coefficient E = 176 L . mol-' . cm-'). The weight-average molecular weight of 
PGA was determined by measuring the intrinsic viscosity of the polymer in 0,19 M NaCI, 0.01 M 
sodium acetate (pH 7,3) at 25 "C using the following relation3'): [q]/(dL. g-I) = 4,l . 
@;94. 
Preparation of drug-polymer conjugates 
The ADR conjugates of PGA were prepared according to the procedure described in the 
previous paper"). Conjugate 3 was prepared by direct coupling of ADR onto PGA using 
N-ethoxycarbonyl-2-ethoxy-1 ,2-dihydroquinoline, EEDQ, as a coupling agent. To a stirred 
solution of PGA (936 mg, 7,26 mmol) and ADR (203 mg; 0,35 mmol) in freshly distilled DMF 
(25 mL) containing N-ethyl morpholine (99 pL; 0,776 mmol) was added EEDQ (105 mg; 0,42 
mmol), and the mixture was stirred overnight at room temperature. The resulting viscous mixture 
was diluted with sodium phosphate buffer (0,l mol . L-'; pH 7,O; 400 mL), and the solution was 
dialyzed against water and freeze-dried. A solution of the crude conjugate was purified on a 
polystyrene-based cation exchange column (20 x 5 cm, Dowex 50W X-8, sodium form) to remove 
free ADR which binds strongly to the conjugates due to x-complex formation, then filtered (0,45 
pm, Flow Pore D) and freeze-dried. To prepare conjugate 4 the oligopeptide spacer was grafted 
prior to coupling of ADR. To a solution of PGA (224 mg; 1,74 mmol of repeating units) and 
saccharin (374 mg; 2,04 mmol) in DMF (4 mL) was addedN,N-carbonyldiimidazole (380 mg; 2,34 
mmol), and the reaction mixture was stirred for 30 min. To this solution was added a solution of 
the N,N,W,N-tetramethylguanidinium (TMG; 0,23 mL; 1,83 mmol) salt of the oligopeptide 
GlyGlyGlyLeu (530 mg; 1,75 mmol) in DMF, and the resulting reaction mixture was stirred for 
3 days. The mixture was added to a phosphate buffer, and the solution was dialyzed against water, 
filtered (0,45 pm) and freeze-dried. The product was converted to the pyridinium salt by passing 
a solution through a column of Dowex 50W X-8, pyridinium form. The eluate fractions containing 
the polymer were combined and freeze-dried. The coupling of ADR as well as the purification and 
isolation of spacer-containing conjugate 4 were performed according to the procedure described 
above for the directly coupled conjugate. 
The UV/VIS absorbance spectra of both ADR conjugates, 3 and 4, are identical with the 
spectrum of free ADR in the mixture of phosphate buffer (10 mmol . L-';  pH 7,O) and methanol 
(50/50 v/v). The load of ADR in the conjugates was determined using the molar absorbance at 
4 8 3 n m , ~  = 12000L.mol- ' .cm- ' .  
Light scattering measurements 
Low-angle laser light scattering (LALLS) measurements were carried out using a Chromatix 
KMX-6 light scattering photometer. Stock solutions of the ADR conjugates for LALLS 
measurements were prepared by dissolving the sodium salts of the conjugates in phosphate buffer 
(phosphate 10 mmol . L -'; pH 7,O; NaCl0,l rnol . L-'), dialyzing exhaustively against the same 
solvent and passing through filters of pore size 0,45 pm (Flow Pore D). Sample solutions of a 
certain concentration were prepared by addition of sufficiently filtered dialyzate to the stock 
solution and were transferred into the light scattering cell through a 0,2 pm filter (Flow Pore D). 
The concentration of the conjugate solution was determined from the absorbance spectrum using 
a calibration curve in the same solvent. The refractive index increment of the sample solution was 
determined by using a Brice Phoenix refractometer. 
Gel permeation chromatography (GPC) 
GPC was performed on a column of Fractogel TSK HW-55s (Merck, Germany). The column 
of 85 x 2,6 cm (inner diameter) was connected to a UV detector (LKB 2138; filter: 278 nm for 
ADR conjugates and 206 nm for carriers) and differential refractometer (Waters R 403). The 
eluent was 10 mmol . L-l sodium phosphate buffer, pH 7,0, containing 0,l mol . L NaC1; the 
flow rate was 32,4 mL/h. The sample solution was prepared by dissolving the conjugate (ca. 4 rng) 
in the eluent (1 mL) and passing the solution through a filter (0,45 pm). 
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Spectroscopic measurements 
Stock solutions for spectroscopic measurements of free ADR and conjugates were prepared in 
water. Sample solutions of a given ionic strength were prepared by adding an appropriate buffer 
solution. For example, 1 mL of phosphate buffer (phosphate 0,l mol . L-l;  NaCl 1,0 mol . L-’; 
pH 6,47) was added to the sample solution in order to prepare 10 mL of phosphate buffer solution 
of conjugates containing 0,l mol . L-‘  NaCl (phosphate 10 mmol * L-’; pH 7,O). Solutions of 
the conjugates and ADR were stored at 4°C in the dark. 
UV/VIS spectra were recorded on a Kontron Instruments Uvikon 930 spectrophotometer at 
room temperature. Fluorescence measurements were carried out with a Perkin-Elmer LS-3 
fluorescence spectrometer. The temperature of the cell holder was kept constant by circulating 
water from a thermostatted bath. The experimental values were corrected for inner filter 
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